Concepedia

Xu Steven Xu

XS

Statistics

Publications

22

Citations

1K

H-Index

17

Active since

2010

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Emory University

University of Science and Technology of China

Harvard University

Xu Steven Xu is an author at Janssen (United States) specializing in pharmacology, pharmacokinetics, and population pharmacokinetics.

Publications per year

2010–2024

22

Publications

22

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Tineke Casneuf, Xu Steven Xu, Homer Adams et al. · Blood Advances · 2017 · 224 citations · Full text

Life Sciences, Immunology, Oncology +16

Stratification of population in NHANES 2009–2014 based on exposure pattern of lead, cadmium, mercury, and arsenic and their association with cardiovascular, renal and respiratory outcomes

Xu Yao, Xu Steven Xu, Yaning Yang et al. · Environment International · 2021 · 129 citations · Full text

Public Health, Health Sciences, Toxicology +16

Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency

Richard J. Auchus, Elizabeth Buschur, Alice Y. Chang et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 93 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

Pamela L. Clemens, Xiaoyu Yan, Henk M. Lokhorst et al. · Clinical Pharmacokinetics · 2016 · 83 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer

Kim Stuyckens, Fred Saad, Xu Steven Xu et al. · Clinical Pharmacokinetics · 2014 · 54 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 22